Evidence map›Paper›PMID 35656982›Full record

Trial reportJournal of the American Heart Association2022

Prognostic Implications of Prestent Pullback Pressure Gradient and Poststent Quantitative Flow Ratio in Patients Undergoing Percutaneous Coronary Intervention.

Neng Dai, Sheng Yuan, Kefei Dou, Rui Zhang, Nan Hu, Jining He, Changdong Guan, Tongqiang Zou, Zheng Qiao, Shaofeng Duan and 5 more

Abstract readClinical Trial
In one paragraph

Trial report in Journal of the American Heart Association, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Novel Non-Hyperemic Coronary Physiology Indices for Vessel Longitudinal Analysis.Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions · 2025
    Observational
  8. Article
  9. Article
  10. Observational
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Neng DaiDepartment of Cardiology Zhongshan HospitalFudan UniversityShanghai Institute of Cardiovascular Diseases Shanghai China.
Sheng YuanState Key Laboratory of Cardiovascular Disease Beijing China.
Kefei DouState Key Laboratory of Cardiovascular Disease Beijing China.ORCID 0000-0002-8372-6338
Rui ZhangState Key Laboratory of Cardiovascular Disease Beijing China.
Nan HuSchool of Electronics and Information Engineering Soochow University Suzhou China.
Jining HeState Key Laboratory of Cardiovascular Disease Beijing China.
Changdong GuanCatheterization Laboratories Fu Wai HospitalNational Center for Cardiovascular DiseasesChinese Academy of Medical Sciences and Peking Union Medical College Beijing China.
Tongqiang ZouCatheterization Laboratories Fu Wai HospitalNational Center for Cardiovascular DiseasesChinese Academy of Medical Sciences and Peking Union Medical College Beijing China.
Zheng QiaoState Key Laboratory of Cardiovascular Disease Beijing China.
Shaofeng DuanGE Healthcare China Shanghai China.
Lihua XieCatheterization Laboratories Fu Wai HospitalNational Center for Cardiovascular DiseasesChinese Academy of Medical Sciences and Peking Union Medical College Beijing China.
Yongfu YuDepartment of Biostatistics School of Public Health The Key Laboratory of Public Health Safety of Ministry of EducationFudan University Shanghai China.
Yingmei ZhangDepartment of Cardiology Zhongshan HospitalFudan UniversityShanghai Institute of Cardiovascular Diseases Shanghai China.ORCID 0000-0001-7686-1534
Bo XuCatheterization Laboratories Fu Wai HospitalNational Center for Cardiovascular DiseasesChinese Academy of Medical Sciences and Peking Union Medical College Beijing China.ORCID 0000-0002-1165-7302
Junbo GeDepartment of Cardiology Zhongshan HospitalFudan UniversityShanghai Institute of Cardiovascular Diseases Shanghai China.ORCID 0000-0002-9360-7332

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background Coronary diffuse disease associates with poor outcomes, but little is known about its role after percutaneous coronary intervention (PCI). We aimed to investigate the prognostic implication of pre-PCI focal or diffuse disease patterns combined with post-PCI quantitative flow ratio (QFR). Methods and Results Pre-PCI QFR derived pullback pressure gradient (PPG) (QFR-PPG) was measured to assess physiological disease patterns for 1685 included vessels; the vessels were classified according to dichotomous pre-PCI QFR-PPG and post-PCI QFR. Vessel-oriented composite outcome, a composite of vessel-related ischemia-driven revascularization, vessel-related myocardial infarction, or cardiac death at 2 years was compared among these groups. Vessels with low pre-PCI PPG (3.9% versus 2.0%, hazard ratio [HR], 1.93; 95% CI, 1.08-3.44;

Indexed as

Coronary Artery DiseaseFractional Flow Reserve, MyocardialPercutaneous Coronary InterventionCoronary AngiographyCoronary VesselsHumansPredictive Value of TestsPrognosisTreatment Outcomepercutaneous coronary interventionprognosispullback pressure gradientquantitative flow ratio

Identifiers

PMID35656982
PMCPMC9238737

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.